Olema Pharmaceuticals, Inc.

NASDAQ:OLMA

11.48 (USD) • At close November 13, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q4
Omzet 0001.8840000000000000000
Kosten van de omzet 00.0940.0880.0880.090.4250.4270.4230.4180.410.4071.5730.050.0310.00900000
Brutowinst 0-0.094-0.0881.796-0.09-0.425-0.427-0.423-0.418-0.41-0.407-1.573-0.05-0.031-0.00900000
Brutowinstmarge 0000.9530000000000000000
Onderzoek- en ontwikkelingskosten 33.22629.10929.88325.87219.45317.98922.82621.58417.62727.05416.00915.97512.52311.9110.6926.2894.6731.9470.7950.91
Algemene en administratieve kosten 4.3954.4214.4564.5443.8893.6126.7765.6355.5956.2397.2455.7825.2394.6124.7583.8423.1950.5390.2480.107
Verkoop- en marketingkosten 000-0.0880000000000000000
Verkoop-, algemene en administratieve kosten 4.3954.4214.4564.4563.8893.6126.7765.6355.5956.2397.2455.7825.2394.6124.7583.8423.1950.5390.2480.107
Overige kosten 000.0170.093-0.079-0.0440.0110.067-0.120.020.0060.01-0.056-0.001000.001000
Bedrijfskosten 37.62133.5334.33930.32823.34221.60129.60227.21923.22233.29323.25421.75717.76216.52215.4510.1317.8682.4861.0431.017
Bedrijfsresultaat -37.621-33.53-34.339-30.416-23.342-21.601-29.602-27.219-23.222-33.293-23.254-21.757-17.762-16.522-15.45-10.131-7.868-2.486-1.043-1.017
Bedrijfsresultaat ratio 000-16.1440000000000000000
Totaal overige inkomsten en kosten netto 3.0663.1483.3693.6441.841.5061.3161.040.5020.4350.2240.1190.0490.1160.11100.0240.033-0.650
Inkomen voor belasting -34.555-30.382-30.97-26.772-21.502-20.095-28.286-26.179-22.72-32.858-23.03-21.638-17.713-16.406-15.339-10.131-7.844-2.453-1.693-1.017
Inkomen voor belasting ratio 000-14.210000000000000000
Belastingkosten 00-3.3524.785-1.919-1.55-1.316-1.04-0.502-0.415-0.224-0.063-0.056-0.0010.11122.1170.0010.0330.0030
Nettowinst -34.555-30.382-30.97-26.772-21.502-20.095-26.97-25.139-22.218-32.858-22.806-21.638-17.713-16.406-15.339-10.131-7.844-2.453-1.693-1.017
Nettowinstmarge 000-14.210000000000000000
WPA (Winst Per Aandeel) -0.6-0.54-0.56-0.49-0.48-0.49-0.67-0.63-0.55-0.82-0.57-0.54-0.45-0.42-0.39-0.5-0.21-0.17-0.12-0.072
Verwaterde WPA -0.6-0.54-0.56-0.49-0.48-0.49-0.67-0.63-0.55-0.82-0.57-0.54-0.45-0.42-0.39-0.5-0.21-0.17-0.12-0.072
EBITDA -37.621-33.436-34.251-30.328-23.252-21.502-29.602-27.122-23.131-33.208-23.17-21.565-17.712-16.491-15.441-10.127-7.842-2.451-1.037-1.014
EBITDA ratio 000-16.0980000000000000000